Rao SV, Kirsch B, Bhatt DL et al (2022) A multicenter, phase 2, randomized, placebo-controlled, double-blind, parallel-group, dose-finding trial of the oral factor XIa inhibitor asundexian to prevent adverse cardiovascular outcomes after acute myocardial infarction
A Comparison of Efficacy Between Cognitive Behavioral Therapy (CBT) and CBT Combined With Medication in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This leaves many patients dealing with excess, sagging skin that obscures their hard-earned results
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
What the clinical trials showed The most widely discussed semaglutide data come from the SUSTAIN programme in type 2 diabetes and the STEP programme in obesity and overweight management